A phase 1B trial involving 20 people showed MOTS-c was safe, but the project didnt move forward because to get the kind of response that we wanted that was clear and substantial it needed to be given at least daily, maybe twice a day, at a pretty large volume, and it was clear that thats not going to be a way to develop a drug, said Cohen, a professor of gerontology, medicine, and biological sciences and dean of USC Leonard Davis School of Gerontology in Los Angeles
Why Would I Get MIC B12 Shots
It is commonly discussed in wellness and performance spaces for its potential role in recovery and soft tissue support
The IV delivers a larger dose gradually and requires more time
Through the Diversity Summer Internship Program (DSIP), I was assigned to the Department of International Health, Johns Hopkins Bloomberg School of Public Health, and was mentored by Dr
Dickerman Z et al